Accelerated neurodegeneration through chaperone-mediated oligomerization of tau
Open accessThe DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
Abstract
Aggregation of tau protein in the brain is associated with a class of neurodegenerative diseases known as tauopathies. FK506 binding protein 51 kDa (FKBP51, encoded by FKBP5) forms a mature chaperone complex with Hsp90 that prevents tau degradation. In this study, we have shown that tau levels are reduced throughout the brains of Fkbp5-/- mice. Recombinant FKBP51 and Hsp90 synergized to block tau clearance through the proteasome, resulting in tau oligomerization. Overexpression of FKBP51 in a tau transgenic mouse model revealed that FKBP51 preserved the species of tau that have been linked to Alzheimer's disease (AD) pathogenesis, blocked amyloid formation, and decreased tangle load in the brain. Alterations in tau turnover and aggregate structure corresponded with enhanced neurotoxicity in mice. In human brains, FKBP51 levels increased relative to age and AD, corresponding with demethylation of the regulatory regions in the FKBP5 gene. We also found that higher FKBP51 levels were associated with AD progression. Our data support a model in which age-associated increases in FKBP51 levels and its interaction with Hsp90 promote neurotoxic tau accumulation. Strategies aimed at attenuating FKBP51 levels or its interaction with Hsp90 have the potential to be therapeutically relevant for AD and other tauopathies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Hsp90:FKBP51 functions in tau proteostasis, increasing its stability and altering phosphorylation states”
From The structure of an Hsp90-immunophilin complex reveals cochaperone recognition of the client maturation state (2021) · cites this paper as Blair et al., 2013
The cited source says what the claim attributes to it.
In the citing paper
“since FKBP5 site-specific demethylation occurs with age (49).”
From Holocaust Exposure Induced Intergenerational Effects on FKBP5 Methylation (2016) · cites this paper as [49]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123 · cited 1×
“Introduction Neurofibrillary tangles, hallmarks of a class of neurodegenerative diseases termed tauopathies, are comprised of microtubule-associated tau protein aggregates that persist in the brain even after neuron death (1).”
Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17
Hutton, M., Lendon, C. L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-Brown, S., Chakraverty, S., Isaacs, A., Grover, A., et al. (1998) · Nature · doi:10.1038/31508 · Cited by 3,498
Adapting Proteostasis for Disease Intervention
Balch, W. E., Morimoto, R. I., Dillin, A., & Kelly, J. W. (2008) · Science · doi:10.1126/science.1141448 · Cited by 2,495
STRUCTURE AND FUNCTIONS OF THE 20S AND 26S PROTEASOMES
Coux, O., Tanaka, K., & Goldberg, A. L. (1996) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.65.070196.004101 · Cited by 2,487 · cited 2×
“3- to 4-times more abundant in cells than 26S proteasomes (35).”
Whitmore, L., & Wallace, B. A. (2008) · Biopolymers · doi:10.1002/bip.20853 · Cited by 2,243
Impairment of the Ubiquitin-Proteasome System by Protein Aggregation
Bence, N. F., Sampat, R. M., & Kopito, R. R. (2001) · Science · doi:10.1126/science.292.5521.1552 · Cited by 2,187
Tau Suppression in a Neurodegenerative Mouse Model Improves Memory Function
SantaCruz, K., Lewis, J., Spires, T., Paulson, J., Kotilinek, L., Ingelsson, M., Guimaraes, A., DeTure, M., Ramsden, M., McGowan, E., et al. (2005) · Science · doi:10.1126/science.1113694 · Cited by 2,014 · cited 1×
“This same model displays cognitive recovery when tau is suppressed, despite continued tangle formation (5, 46).”
Transmission and spreading of tauopathy in transgenic mouse brain
Clavaguera, F., Bolmont, T., Crowther, R. A., Abramowski, D., Frank, S., Probst, A., Fraser, G., Stalder, A. K., Beibel, M., Staufenbiel, M., et al. (2009) · Nature Cell Biology · doi:10.1038/ncb1901 · Cited by 1,803
The Amyloid State of Proteins in Human Diseases
Eisenberg, D., & Jucker, M. (2012) · Cell · doi:10.1016/j.cell.2012.02.022 · Cited by 1,744
Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease
Gómez‐Isla, T., Hollister, R., West, H., Mui, S., Growdon, J. H., Petersen, R. C., Parisi, J. E., & Hyman, B. T. (1997) · Annals of Neurology · doi:10.1002/ana.410410106 · Cited by 1,489 · cited 1×
“However, levels of neuronal death in AD far exceed what is expected based on the observed numbers of tau tangles (2), suggesting that a different mechanism is primarily responsible for neurodegeneration.”
Allele-specific FKBP5 DNA demethylation mediates gene–childhood trauma interactions
Klengel, T., Mehta, D., Anacker, C., Rex-Haffner, M., Pruessner, J. C., Pariante, C. M., Pace, T. W. W., Mercer, K. B., Mayberg, H. S., Bradley, B., et al. (2013) · Nature Neuroscience · doi:10.1038/nn.3275 · Cited by 1,447 · cited 5×
“CpG sites in functional glucocorticoid response elements in intron 7, intron 2, and the promoter (Figure 7) of FKBP5 (54).”
InfluentialSelf-citationPropagation of Tau Pathology in a Model of Early Alzheimer's Disease
de Calignon, A., Polydoro, M., Suárez-Calvet, M., William, C., Adamowicz, D. H., Kopeikina, K. J., Pitstick, R., Sahara, N., Ashe, K. H., Carlson, G. A., et al. (2012) · Neuron · doi:10.1016/j.neuron.2011.11.033 · Cited by 1,427
PONDR-FIT: A meta-predictor of intrinsically disordered amino acids
Xue, B., Dunbrack, R. L., Williams, R. W., Dunker, A. K., & Uversky, V. N. (2010) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2010.01.011 · Cited by 1,223 · cited 1×
“The PONDR-FIT algorithm, one of the most accurate disorder predictors (38), con-”
Self-citationThe tetratricopeptide repeat: a structural motif mediating protein-protein interactions
Blatch, G. L., & Lässle, M. (1999) · BioEssays · doi:10.1002/(sici)1521-1878(199911)21:11<932::aid-bies5>3.0.co;2-n · Cited by 1,211 · cited 2×
“FKBP51 is a profolding Hsp90 cochap-erone that forms a complex with Hsp90 via the tetratricopep-tide (TPR) domain (25, 26), a region also found on other Hsp90 cochaperones, including the carboxyl terminus of Hsp70-in-teracting protein (CHIP; also known as STUB1 ) and FK506 binding protein 52 (FKBP52; also known as FKB…”
Evidence for a Partially Folded Intermediate in α-Synuclein Fibril Formation
Uversky, V. N., Li, J., & Fink, A. L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010907200 · Cited by 1,096 · cited 1×
“Since altering the structure of aggregation-prone proteins is known to contribute to their pathogenic assembly into fibrillar structures (40–43), we speculated that Hsp90 alone and Hsp90 with FKBP51 could alter tau fibril assembly.”
Self-citationConformational constraints for amyloid fibrillation: the importance of being unfolded
Uversky, V. N., & Fink, A. L. (2004) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2003.12.008 · Cited by 1,015
Self-citationTrans-Synaptic Spread of Tau Pathology In Vivo
Liu, L., Drouet, V., Wu, J. W., Witter, M. P., Small, S. A., Clelland, C., & Duff, K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031302 · Cited by 1,002 · cited 1×
“These soluble tau species may also be able to spread from neuron to neuron in a fashion similar to that of prions, further establishing their role in perpetuating pathogenicity (6–8).”
Cellular Defenses against Unfolded Proteins
Sherman, M. Y., & Goldberg, A. L. (2001) · Neuron · doi:10.1016/s0896-6273(01)00177-5 · Cited by 991 · cited 1×
“Levels of Hsps diminish with age, and roles for these proteins in neurodegenerative disease in relation to the age of onset have been proposed in several models (15).”
Binder, E. B., Salyakina, D., Lichtner, P., Wochnik, G. M., Ising, M., Pütz, B., Papiol, S., Seaman, S., Lucae, S., Kohli, M. A., et al. (2004) · Nature Genetics · doi:10.1038/ng1479 · Cited by 977 · cited 1×
“org Volume 123 Number 10 October 2013 4159 psychiatric diseases (24).”
Self-citationTauopathy in Drosophila : Neurodegeneration Without Neurofibrillary Tangles
Wittmann, C. W., Wszolek, M. F., Shulman, J. M., Salvaterra, P. M., Lewis, J., Hutton, M., & Feany, M. B. (2001) · Science · doi:10.1126/science.1062382 · Cited by 939 · cited 1×
“This provides further evidence that other forms of tau, besides those that are pathologically visible in postmortem tissue like tangles, are highly neurotoxic (5, 45, 55, 56).”
Oddo, S., Billings, L., Kesslak, J. P., Cribbs, D. H., & LaFerla, F. M. (2004) · Neuron · doi:10.1016/j.neuron.2004.07.003 · Cited by 780
CHIP and Hsp70 regulate tau ubiquitination, degradation and aggregation
Petrucelli, L. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh083 · Cited by 723 · cited 1×
“an Hsp90 cochaperone that can facilitate tau clearance through the proteasome (52, 53), increasing FKBP51 levels were able to displace CHIP from Hsp90 and preserve tau levels (Figure 6E).”
Ramsden, M., Kotilinek, L., Forster, C., Paulson, J., McGowan, E., SantaCruz, K., Guimaraes, A., Yue, M., Lewis, J., Carlson, G., et al. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.3279-05.2005 · Cited by 702
Temporal dynamics and genetic control of transcription in the human prefrontal cortex
Colantuoni, C., Lipska, B. K., Ye, T., Hyde, T. M., Tao, R., Leek, J. T., Colantuoni, E. A., Elkahloun, A. G., Herman, M. M., Weinberger, D. R., et al. (2011) · Nature · doi:10.1038/nature10524 · Cited by 685 · cited 2×
“The variability in age of onset for AD and other tauopathies, even those caused by bona fide hereditary mutations, indicates that other environmental- and experience-based genetic modifiers are involved in the production of pathogenic tau species (12, 13).”
Dickey, C. A., Kamal, A., Lundgren, K., Klosak, N., Bailey, R. M., Dunmore, J., Ash, P., Shoraka, S., Zlatkovic, J., Eckman, C. B., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29715 · Cited by 642
Self-citationSchweers, O., Schönbrunn-Hanebeck, E., Marx, A., & Mandelkow, E. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)51080-8 · Cited by 567 · cited 1×
“shown, tau is an intrinsically disordered protein, and its CD spectra have a minima at 200 nm (36).”
Identification of oligomers at early stages of tau aggregation in Alzheimer's disease
Lasagna‐Reeves, C. A., Castillo‐Carranza, D. L., Sengupta, U., Sarmiento, J., Troncoso, J., Jackson, G. R., & Kayed, R. (2012) · The FASEB Journal · doi:10.1096/fj.11-199851 · Cited by 527 · cited 3×
“The mixtures of these proteins were then analyzed by dot blot with the anti-tau oligomer–specific antibody, T22 (3).”
InfluentialSelf-citationCaspase activation precedes and leads to tangles
de Calignon, A., Fox, L. M., Pitstick, R., Carlson, G. A., Bacskai, B. J., Spires-Jones, T. L., & Hyman, B. T. (2010) · Nature · doi:10.1038/nature08890 · Cited by 517 · cited 3×
“For example, in the rTg4510 tau transgenic mice, neurons with tau tangle structures are longer lived (4, 67).”
Bennett, E. J., Bence, N. F., Jayakumar, R., & Kopito, R. R. (2005) · Molecular Cell · doi:10.1016/j.molcel.2004.12.021 · Cited by 509 · cited 1×
“These substrates can then have detrimental consequences to the proteostasis system and general cellular health (62–65).”
Cribbs, D. H., Berchtold, N. C., Perreau, V., Coleman, P. D., Rogers, J., Tenner, A. J., & Cotman, C. W. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-179 · Cited by 499 · cited 1×
“FKBP51 mRNA expression was measured via microarray analyses (51) in young (ages 20 to 59 years; n = 22, mean 35.”
Self-citationThe prolyl isomerase Pin1 regulates amyloid precursor protein processing and amyloid-β production
Pastorino, L., Sun, A., Lu, P.-J., Zhou, X. Z., Balastik, M., Finn, G., Wulf, G., Lim, J., Li, S.-H., Li, X., et al. (2006) · Nature · doi:10.1038/nature04543 · Cited by 487
Accumulation of Pathological Tau Species and Memory Loss in a Conditional Model of Tauopathy
Berger, Z., Roder, H., Hanna, A., Carlson, A., Rangachari, V., Yue, M., Wszolek, Z., Ashe, K., Knight, J., Dickson, D., et al. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.0587-07.2007 · Cited by 485 · cited 3×
“In this way, FKBP51 causes Hsp90 to alter its structural influence on tau, leading to the formation of nonamyloid tau aggregates and oligomeric tau species, which have both been implicated as the primary toxic tau species that facilitate neurode-generation (4, 5, 45, 46).”
Role of the prolyl isomerase Pin1 in protecting against age-dependent neurodegeneration
Liou, Y.-C., Sun, A., Ryo, A., Zhou, X. Z., Yu, Z.-X., Huang, H.-K., Uchida, T., Bronson, R., Bing, G., Li, X., et al. (2003) · Nature · doi:10.1038/nature01832 · Cited by 435 · cited 1×
“FKBP51 possesses properties that are similar to those of the cis -trans peptidyl-prolyl isomerase Pin1, which has been reported on extensively (21–23); however, much less is known about the role of FKBP51 in the brain despite its genetic association to human psychiatric diseases (24).”
Regulation of Hsp90 ATPase activity by tetratricopeptide repeat (TPR)-domain co-chaperones
Prodromou, C. (1999) · The EMBO Journal · doi:10.1093/emboj/18.3.754 · Cited by 425 · cited 1×
“Consistent with previous reports, FKBP51 and Hsp90 showed substantial ordered secondary structure (28, 37).”
Spires, T. L., Orne, J. D., SantaCruz, K., Pitstick, R., Carlson, G. A., Ashe, K. H., & Hyman, B. T. (2006) · The American Journal of Pathology · doi:10.2353/ajpath.2006.050840 · Cited by 401 · cited 1×
“These mice have abundant Hsp90 levels and low basal FKBP51 levels at 6 months of age, and they are the best model to recapitulate human tau pathobiology (5, 45, 47–49).”
Proteasomal degradation of tau protein
David, D. C., Layfield, R., Serpell, L., Narain, Y., Goedert, M., & Spillantini, M. G. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01137.x · Cited by 327 · cited 2×
“we used a reconstituted in vitro assay, as previously described (32).”
Lee, R. S., Tamashiro, K. L. K., Yang, X., Purcell, R. H., Harvey, A., Willour, V. L., Huo, Y., Rongione, M., Wand, G. S., & Potash, J. B. (2010) · Endocrinology · doi:10.1210/en.2010-0225 · Cited by 275 · cited 1×
“We show that FKBP5 methylation is reduced both with age and in disease, which could be one factor leading to increased FKBP51 expression (54, 57, 58).”
Luo, W., Dou, F., Rodina, A., Chip, S., Kim, J., Zhao, Q., Moulick, K., Aguirre, J., Wu, N., Greengard, P., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701055104 · Cited by 274 · cited 1×
“We and others have shown that inhibiting Hsp90 can promote tau clearance, suggesting that Hsp90 is acting to protect tau in neurons for unknown reasons (16, 18, 19).”
Dickey, C. A., Yue, M., Lin, W.-L., Dickson, D. W., Dunmore, J. H., Lee, W. C., Zehr, C., West, G., Cao, S., Clark, A. M. K., et al. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.0746-06.2006 · Cited by 248
Self-citationCortisol and Alzheimer's disease, I: Basal studies
(1986) · American Journal of Psychiatry · doi:10.1176/ajp.143.3.300 · Cited by 246 · cited 1×
“Additionally, since the FKBP5 gene is responsive to stress hormone (54), the levels of which increase in AD (59), FKBP51 could be exploited as a novel biomarker to compliment other such molecules for evaluating AD risk.”
Dumanchin, C., Camuzat, A., Campion, D., Verpillat, P., Hannequin, D., Dubois, B., Saugier-Veber, P., Martin, C., Penet, C., Charbonnier, F., et al. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.11.1825 · Cited by 244 · cited 1×
“Mutations in MAPT , the gene encoding tau, can also lead to the production of soluble tau conformers with pathogenic potential, leading to rarer tauopathies, such as progressive supranuclear palsy and frontal temporal dementia with parkinsonism linked to chromosome 17 (9–11).”
Cochaperone immunophilin FKBP52 is critical to uterine receptivity for embryo implantation
Tranguch, S., Cheung-Flynn, J., Daikoku, T., Prapapanich, V., Cox, M. B., Xie, H., Wang, H., Das, S. K., Smith, D. F., & Dey, S. K. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505775102 · Cited by 232 · cited 1×
“Mice were generated as previously described (30, 31).”
Comparing whole genomes using DNA microarrays
Gresham, D., Dunham, M. J., & Botstein, D. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2335 · Cited by 231 · cited 1×
“The variability in age of onset for AD and other tauopathies, even those caused by bona fide hereditary mutations, indicates that other environmental- and experience-based genetic modifiers are involved in the production of pathogenic tau species (12, 13).”
Protein oxidation and 20S proteasome-dependent proteolysis in mammalian cells
Shringarpure, R., Grune, T., & Davies, K. J. A. (2001) · Cellular and Molecular Life Sciences · doi:10.1007/pl00000787 · Cited by 222
The Hsp90 cochaperone, FKBP51, increases Tau stability and polymerizes microtubules
Jinwal, U. K., Koren, J., Borysov, S. I., Schmid, A. B., Abisambra, J. F., Blair, L. J., Johnson, A. G., Jones, J. R., Shults, C. L., O'Leary, J. C., et al. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.4815-09.2010 · Cited by 214 · cited 5×
“In addition, FKBP51 was previously found to slow the degradation of tau by chymotrypsin, the major protease of the 20S proteasome (17).”
InfluentialSelf-citationFunctions of the retinoblastoma protein
Kaelin, W. G. (1999) · BioEssays · doi:10.1002/(sici)1521-1878(199911)21:11<950::aid-bies7>3.0.co;2-d · Cited by 208
Pirkl, F., & Buchner, J. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.4595 · Cited by 179 · cited 3×
“Consistent with previous reports, FKBP51 and Hsp90 showed substantial ordered secondary structure (28, 37).”
O'Leary, J. C., Li, Q., Marinec, P., Blair, L. J., Congdon, E. E., Johnson, A. G., Jinwal, U. K., Koren, J., Jones, J. R., Kraft, C., et al. (2010) · Molecular Neurodegeneration · doi:10.1186/1750-1326-5-45 · Cited by 176 · cited 1×
“This same model displays cognitive recovery when tau is suppressed, despite continued tangle formation (5, 46).”
Self-citationTriggers of Full-Length Tau Aggregation: A Role for Partially Folded Intermediates
Chirita, C. N., Congdon, E. E., Yin, H., & Kuret, J. (2005) · Biochemistry · doi:10.1021/bi0500123 · Cited by 166 · cited 1×
“Since altering the structure of aggregation-prone proteins is known to contribute to their pathogenic assembly into fibrillar structures (40–43), we speculated that Hsp90 alone and Hsp90 with FKBP51 could alter tau fibril assembly.”
Dickey, C. A., Dunmore, J., Lu, B., Wang, J., Lee, W. C., Kamal, A., Burrows, F., Eckman, C., Hutton, M., & Petrucelli, L. (2006) · The FASEB Journal · doi:10.1096/fj.05-5343fje · Cited by 160 · cited 1×
“We and others have shown that inhibiting Hsp90 can promote tau clearance, suggesting that Hsp90 is acting to protect tau in neurons for unknown reasons (16, 18, 19).”
Self-citationRadanyi, C., Chambraud, B., & Baulieu, E. E. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.23.11197 · Cited by 155 · cited 1×
“tide (TPR) domain (25, 26), a region also found on other Hsp90 cochaperones, including the carboxyl terminus of Hsp70-interacting protein (CHIP; also known as STUB1) and FK506 binding protein 52 (FKBP52; also known as FKBP4) (27, 28).”
Binding of Amyloid β Protein to the 20 S Proteasome
Gregori, L., Hainfeld, J. F., Simon, M. N., & Goldgaber, D. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.1.58 · Cited by 151
Sun, A., Nguyen, X. V., & Bing, G. (2002) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215540205000403 · Cited by 139 · cited 1×
“Gallyas silver stains the same structure as Thioflavin T (50), but Gallyas lacks the fluorescent properties of Thioflavin T.”
Spires-Jones, T. L., de Calignon, A., Matsui, T., Zehr, C., Pitstick, R., Wu, H.-Y., Osetek, J. D., Jones, P. B., Bacskai, B. J., Feany, M. B., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3072-08.2008 · Cited by 137
Brunden, K. R., Trojanowski, J. Q., & Lee, V. M.-Y. (2008) · Journal of Alzheimer's Disease · doi:10.3233/jad-2008-14406 · Cited by 125
A New Anti-Depressive Strategy for the Elderly: Ablation of FKBP5/FKBP51
O'Leary, J. C., Dharia, S., Blair, L. J., Brady, S., Johnson, A. G., Peters, M., Cheung-Flynn, J., Cox, M. B., de Erausquin, G., Weeber, E. J., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024840 · Cited by 122 · cited 1×
“Mice were generated as previously described (30, 31).”
Self-citationAbisambra, J. F., Blair, L. J., Hill, S. E., Jones, J. R., Kraft, C., Rogers, J., Koren, J., Jinwal, U. K., Lawson, L., Johnson, A. G., et al. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.3155-10.2010 · Cited by 116 · cited 13×
“Both phospho-tau (pT231) and total tau (H150) were significantly pre-served in mice injected with FKBP51 AAV9 particles compared with GFP AAV9–injected littermates.”
InfluentialSelf-citationDifferential Impact of Tetratricopeptide Repeat Proteins on the Steroid Hormone Receptors
Schülke, J.-P., Wochnik, G. M., Lang-Rollin, I., Gassen, N. C., Knapp, R. T., Berning, B., Yassouridis, A., & Rein, T. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011717 · Cited by 105 · cited 2×
“Based on these data, we hypothesized that in human tauopathies, increasing levels of FKBP51 could allow it to usurp Hsp90 from other cochaperones with lower affinity, causing it to produce toxic tau oligomers, rather than sequester tau into more benign amyloid fibrils (29).”
Are Tangles as Toxic as They Look?
Spires-Jones, T. L., Kopeikina, K. J., Koffie, R. M., de Calignon, A., & Hyman, B. T. (2011) · Journal of Molecular Neuroscience · doi:10.1007/s12031-011-9566-7 · Cited by 104 · cited 1×
“This provides further evidence that other forms of tau, besides those that are pathologically visible in postmortem tissue like tangles, are highly neurotoxic (5, 45, 55, 56).”
Two FKBP-related proteins are associated with progesterone receptor complexes.
Smith, D. F., Baggenstoss, B. A., Marion, T. N., & Rimerman, R. A. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)46853-0 · Cited by 103 · cited 1×
“tide (TPR) domain (25, 26), a region also found on other Hsp90 cochaperones, including the carboxyl terminus of Hsp70-interacting protein (CHIP; also known as STUB1) and FK506 binding protein 52 (FKBP52; also known as FKBP4) (27, 28).”
Yang, X., Ewald, E. R., Huo, Y., Tamashiro, K. L., Salvatori, R., Sawa, A., Wand, G. S., & Lee, R. S. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.03.035 · Cited by 97 · cited 1×
“We show that FKBP5 methylation is reduced both with age and in disease, which could be one factor leading to increased FKBP51 expression (54, 57, 58).”
Central and Peripheral Endorphins: Basic and Clinical Aspects
Davis, G. C. (1986) · American Journal of Psychiatry · doi:10.1176/ajp.143.5.664-a · Cited by 91
A New Mutation of the τ Gene, G303V, in Early-Onset Familial Progressive Supranuclear Palsy
Ros, R., Thobois, S., Streichenberger, N., Kopp, N., Sánchez, M. P., Pérez, M., Hoenicka, J., Avila, J., Honnorat, J., & de Yébenes, J. G. (2005) · Archives of Neurology · doi:10.1001/archneur.62.9.1444 · Cited by 91
Dickey, C. A., Kraft, C., Jinwal, U. K., Koren, J., Johnson, A. G., Anderson, L. C., Lebson, L. A., Lee, D. C., Dickson, D. W., de Silva, R., et al. (2008) · American Journal Of Pathology · doi:10.2353/ajpath.2009.080764 · Cited by 89 · cited 3×
“Therefore, 2 months following these injections, 6-month-old mice were harvested and examined histologically, as previously described (47).”
Self-citationGrune, T., Botzen, D., Engels, M., Voss, P., Kaiser, B., Jung, T., Grimm, S., Ermak, G., & Davies, K. J. A. (2010) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2010.05.008 · Cited by 85 · cited 1×
“dation via the 20S proteasome, a process shown to be a major route of tau clearance (32, 33).”
Thompson, A. D., Scaglione, K. M., Prensner, J., Gillies, A. T., Chinnaiyan, A., Paulson, H. L., Jinwal, U. K., Dickey, C. A., & Gestwicki, J. E. (2012) · ACS Chemical Biology · doi:10.1021/cb3002599 · Cited by 81 · cited 1×
“One group of age-affected genes that can also modulate tau proteostasis is the molecular chaperone family, which includes heat shock proteins (Hsps), proteins whose expression increases under conditions of stress (14).”
Self-citationConformational Prerequisites for Formation of Amyloid Fibrils from Histones
Munishkina, L. A., Fink, A. L., & Uversky, V. N. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.06.094 · Cited by 80
Self-citationStructure and elasticity of microtubule-associated protein tau
Lichtenberg-Kraag, B., Mandelkow�, E., Hagestedt, T., & Mandelkow�, E. (1988) · Nature · doi:10.1038/334359a0 · Cited by 74 · cited 1×
“This type of control of tau degradation may be unique to tau because of its high level of disorder (60).”
Binding of Hsp90 to Tau Promotes a Conformational Change and Aggregation of Tau Protein
Tortosa, E., Santa-Maria, I., Moreno, F., Lim, F., Perez, M., & Avila, J. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-1049 · Cited by 70 · cited 2×
“0 days–1) consistent with previous findings (20).”
Marx, J. (2007) · Science · doi:10.1126/science.316.5830.1416 · Cited by 51
Gillardon, F., Kloß, A., Berg, M., Neumann, M., Mechtler, K., Hengerer, B., & Dahlmann, B. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04438.x · Cited by 43
Köberle, M., Göppel, D., Grandl, T., Gaentzsch, P., Manncke, B., Berchtold, S., Müller, S., Lüscher, B., Asselin-Labat, M.-L., Pallardy, M. J., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040730 · Cited by 18 · cited 1×
“FKBP51 possesses properties that are similar to those of the cis -trans peptidyl-prolyl isomerase Pin1, which has been reported on extensively (21–23); however, much less is known about the role of FKBP51 in the brain despite its genetic association to human psychiatric diseases (24).”
O’Leary, J. C., Koren, J., & Dickey, C. A. (2011) · Journal of Molecular Neuroscience · doi:10.1007/s12031-011-9540-4 · Cited by 2 · cited 1×
“Significant methylation was found in intron 2 at P4_S1_CG1 ( † P = 0.0244). folded or abnormally folded proteins into amyloid β -sheet structures may be more beneficial to neurons than allowing these intermediates to traverse the intracellular milieu (69–71).”
InfluentialSelf-citation
Cited by
Holocaust Exposure Induced Intergenerational Effects on FKBP5 Methylation
Yehuda, R., Daskalakis, N. P., Bierer, L. M., Bader, H. N., Klengel, T., Holsboer, F., & Binder, E. B. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.08.005 · Cited by 782
“F1: 45 years), which could explain their 12% methylation difference at bin 3/site 6, since FKBP5 site-specific demethylation occurs with age (49).”
BackgroundSelf-citationThe role of protein clearance mechanisms in organismal ageing and age-related diseases
Vilchez, D., Saez, I., & Dillin, A. (2014) · Nature Communications · doi:10.1038/ncomms6659 · Cited by 689
Gene–Stress–Epigenetic regulation of FKBP5: clinical and translational implications
Zannas, A. S., Wiechmann, T., Gassen, N. C., & Binder, E. B. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2015.235 · Cited by 622
“More recently, postmortem studies have found FKBP5 overexpression in several brain regions in association with Alzheimer’s disease and schizophrenia (Blair et al, 2013; Sinclair et al, 2013).”
BackgroundSelf-citationTau Protein Modifications and Interactions: Their Role in Function and Dysfunction
Mietelska-Porowska, A., Wasik, U., Goras, M., Filipek, A., & Niewiadomska, G. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15034671 · Cited by 404
“dephosphorylation [192] and its overexpression enhanced neuronal loss in the rTg4510 tau transgenic mouse model [196].”
BackgroundThe Hsp70/Hsp90 Chaperone Machinery in Neurodegenerative Diseases
Lackie, R. E., Maciejewski, A., Ostapchenko, V. G., Marques-Lopes, J., Choy, W.-Y., Duennwald, M. L., Prado, V. F., & Prado, M. A. M. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00254 · Cited by 374
“Dickey and colleagues also found that FKBP51 expression is increased with age and in AD (Blair et al., 2013).”
Background
Metadata
- Authors
- Blair, L. J., Nordhues, B. A., Hill, S. E., Scaglione, K. M., O’Leary, J. C., Fontaine, S. N., Breydo, L., Zhang, B., Li, P., Wang, L., Cotman, C., Paulson, H. L., Muschol, M., Uversky, V. N., Klengel, T., Binder, E. B., Kayed, R., Golde, T. E., Berchtold, N., & Dickey, C. A.
- Affiliations
- University of South Florida (US)
- University of Michigan (US)
- University of California, Irvine (US)
- Max Planck Institute of Psychiatry (DE)
- The University of Texas Medical Branch at Galveston (US)
- University of Florida (US)
- Corresponding author
- Wang, Li
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2013-09-03
- Volume
- 123
- Issue
- 10
- Pages
- 4158-4169
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC3784538
- OpenAlex
- W2056613924
- Cited by
- 322
- References
- 72
- Citations by year
- 2026: 24 · 2025: 34 · 2024: 25 · 2023: 28 · 2022: 34 · 2021: 20 · 2020: 24 · 2019: 26 · 2018: 19 · 2017: 18 · 2016: 21 · 2015: 24 · 2014: 23 · 2013: 2
- FWCI
- 16.20
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Digital Commons - University of South Florida (University of South Florida) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Max Planck Digital Library (submittedVersion)
- MPG.PuRe (Max Planck Society) (submittedVersion)
- Funders
- American Federation for Aging Research
- BrightFocus Foundation
- University of South Florida
- National Institutes of Health
- University of California, Irvine
- National Institute on Aging (P01AG000538, R01AG034667, P50AG016573)
- National Institute of Neurological Disorders and Stroke (K99NS073936, R00NS073936, R01NS073899, NS073899)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- tau protein, tau oligomerization, tau aggregation, tauopathy, Alzheimer's disease, FKBP51, HSP90, proteasome, tau clearance, amyloid fibril formation, neurotoxicity, tau transgenic mice
- MeSH terms
- Tacrolimus Binding Protein 5, Adult, Aged, Aged, 80 and over, Alzheimer Disease, Amyloid, Animals, Female, Gene Expression Regulation, Humans, Male, Middle Aged, Gene Expression, Case-Control Studies, tau Proteins, Mice, Knockout, HSP90 Heat-Shock Proteins, DNA Methylation, Protein Structure, Quaternary, Tacrolimus Binding Proteins, Proteasome Endopeptidase Complex, Mice, Protein Multimerization, Young Adult, CA3 Region, Hippocampal, HEK293 Cells, Proteolysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.